The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: Initial first in man clinical results

International Journal of Cardiology

Volumn 199, Issue , 2015, Pages 18-24

  Lee, Randall J ^a,b   Hinson, Andy ^c   Bauernschmitt, Robert ^d   Matschke, Klaus ^e   Fang, Qi ^a,b   Mann, Douglas L ^f   Dowling, Robert ^c   Schiller, Nelson ^a,b   Sabbah, Hani N ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Institute for Regeneration Medicine University of California San Francisco ^*  (United States)

^d UNIVERSITY OF ULM   (Germany)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HENRY FORD HOSPITAL   (United States)

Author keywords

Alginate hydrogel; Heart failure; Tissue engineering

Indexed keywords

BIOPOLYMER; CALCIUM ALGINATE; ALGINIC ACID; HYDROGEL;

ADULT; AGED; ARTICLE; CARDIAC IMPLANT; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BYPASS GRAFT; FEASIBILITY STUDY; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYDROGEL; MALE; MITRAL VALVE REPAIR; OPEN HEART SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SAFETY; SURGICAL MORTALITY; TREATMENT OUTCOME; ADMINISTRATION AND DOSAGE; ADOLESCENT; AMBULATORY ELECTROCARDIOGRAPHY; CARDIOMYOPATHY, DILATED; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART SURGERY; HEART VENTRICLE; INJECTION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR; TISSUE ENGINEERING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALGINATES; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYDROGEL; INJECTIONS; MALE; MIDDLE AGED; STROKE VOLUME; TIME FACTORS; TISSUE ENGINEERING; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84941549443     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.06.111     Document Type: Article

References (21)

1. J.J. McMurray, and S. Stewart Heart failure: epidemiology, aetiology, and prognosis of heart failure Heart 83 2000 596 602
2. J. Chen, S.L. Normand, Y. Wang, and H.M. Krumholz National and regional trends in heart failure hospitalization and mortality rates for medicare beneficiaries, 1998-2008 JAMA 306 15 2011 1669 1678
3. S.S. Mihardja, J.A. Gonzales, D. Gao, and et al. The effect of a peptide-modified thermo-reversible methylcellulose on wound healing and LV function in a chronic myocardial infarction rodent model Biomaterials 34 35 2013 8869 8877
4. M. Song, H. Jang, J. Lee, J.H. Kim, S.H. Kim, K. Sun, and Y. Park Regeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKP Biomaterials 35 2014 2436 2445
5. J.L. Ungerleider, and K.L. Christman Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress Stem Cells Transl. Med. 3 9 2014 1090 1099
6. J. Yu, K.L. Christman, E. Chin, R.E. Sievers, M. Saeed, and R.J. Lee Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy J. Thorac. Cardiovasc. Surg. 137 1 2009 180 187
7. H.N. Sabbah, M. Wang, R.C. Gupta, and et al. Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure JACC Heart Fail. 1 3 2013 252 258
8. K. Fukamachi, and P.M. McCarthy Initial safety and feasibility clinical trial of the myosplint device J. Card. Surg. 20 6 2005 S43 S47
9. D.L. Mann, S.H. Kubo, H.N. Sabbah, R.C. Starling, M. Jessup, J.K. Oh, and M.A. Acker Beneficial effects of the CorCap cardiac support device: five-year results from the Acorn Trial J. Thorac. Cardiovasc. Surg. 143 5 2012 1036 1042
10. C.T. Klodell Jr., J.M. Aranda Jr., D.C. McGiffin, and et al. Worldwide surgical experience with the Paracor HeartNet cardiac restraint device J. Thorac. Cardiovasc. Surg. 135 1 2008 188 195
11. L.C. Lee, S.T. Wall, D. Klepach, L. Ge, and et al. Algisyl-LVR™ with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart Int. J. Cardiol. 168 3 2013 Oct 3 2022 2028
12. DL Mann, M.A. Acker, M. Jessup, H.N. Sabbah, R.C. Starling, and S.H. Kubo Acorn Trial Principal Investigators and Study Coordinators. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy Ann. Thorac. Surg. 84 4 2007 1226 1235
13. C.T. Klodell, J.M. Aranda, D.C. McGiffin, and et al. Worldwide surgical experience with the Paracor HeartNet cardiac restraint device J. Thorac. Cardiovasc. Surg. 135 1 2008 188 195
14. E.D. Verrier, S.K. Shernan, K.M. Taylor, and et al. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial JAMA 291 19 2004 May 19 2319 2327 (Erratum in: JAMA.2006;295(2):164)
15. P. Menasche, A.A. Hagege, J.T. Vilquin, and et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction J. Am. Coll. Cardiol. 41 2003 1078 1083
16. P.C. Smits, R.J. van Geuns, D. Poldermans, and et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up J. Am. Coll. Cardiol. 42 2003 2063 2069
17. G.N. Kay, A.E. Epstein, and V.J. Plumb Resetting of ventricular tachycardia by single extrastimuli. Relation to slow conduction within the reentrant circuit Circulation 81 5 1990 1507 1519
18. F.C. de Carvalho, F.M. Consolim-Colombo, C.A. Pastore, M.C. Rubira, J.C. Menegüetti, E.M. Krieger, and M. Wajngarten Acute reduction of ventricular volume decreases QT interval dispersion in elderly subjects with and without heart failure Am. J. Physiol. Heart Circ. Physiol. 288 5 2005 H2171 H2176
19. G. Di Bella, C. Passino, G.D. Aquaro, and et al. Different substrates of non-sustained ventricular tachycardia in post-infarction patients with and without left ventricular dilatation J. Card. Fail. 16 1 2010 61 68
20. M. St John Sutton, D. Lee, J.L. Rouleau, S. Goldman, T. Plappert, E. Braunwald, and M.A. Pfeffer Left ventricular remodeling and ventricular arrhythmias after myocardial infarction Circulation 107 20 2003 2577 2582
21. Z.K. Wu, T. Iivainen, E. Pehkonen, J. Laurikka, and M.R. Tarkka Perioperative and postoperative arrhythmia in three-vessel coronary artery disease patients and antiarrhythmic effects of ischemic preconditioning Eur. J. Cardiothorac. Surg. 23 4 2003 578 584